Oppenheimer on BridgeBio Oncology Therapeutics, In (BBOT): 'We think the lack of idiosyncratic toxicity is particularly notable for BBO-10203'

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/17/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. SNDK
6. GNK
7. HTFL
8. ADYEN:NA
9. DVLT
10. ADYYF

Go back to Oppenheimer on BridgeBio Oncology Therapeutics, In (BBOT): 'We think the lack of idiosyncratic toxicity is particularly notable for BBO-10203'
(NASDAQ: BBOT) Delayed: 9.06 --0 (-0%)
Previous Close $9.06    52 Week High $ 
Open $9.06    52 Week Low $ 
Day High $9.06    P/E N/A 
Day Low $9.06    EPS $ 
Volume 14,359       

(NASDAQ: ERAS) Delayed: 18.38 --0 (-0%)
Previous Close $18.38    52 Week High $ 
Open $18.38    52 Week Low $ 
Day High $18.38    P/E N/A 
Day Low $18.38    EPS $ 
Volume 2       

(NASDAQ: RVMD) Delayed: 203.71 --0 (-0%)
Previous Close $203.71    52 Week High $ 
Open $203.71    52 Week Low $ 
Day High $203.71    P/E N/A 
Day Low $203.71    EPS $ 
Volume 261